The Role of Serum Pepsinogen in Detection of Gastric Cancer.
10.5230/jkgca.2009.9.4.167
- Author:
Hyong Kyun RYU
1
;
Jeon Woo PARK
;
Keon Ho LEE
;
Chang Ho JEON
;
Ho Joon LEE
;
Hyun Dong CHAE
Author Information
1. Department of Surgery, Pohang St. Mary's Hospital, Pohang, Korea.
- Publication Type:Original Article
- Keywords:
Gastric adenocarcinoma;
Screening;
Pepsinogen;
Receiver operator characteristics (ROC) curves
- MeSH:
Adenocarcinoma;
Gastritis, Atrophic;
Humans;
Intestinal Neoplasms;
Mass Screening;
Pepsinogen A;
Sensitivity and Specificity;
Stomach Neoplasms
- From:Journal of the Korean Gastric Cancer Association
2009;9(4):167-171
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: This study was done to determine the usefulness of serum pepsinogen (PG) levels as a screening method for gastric cancer, and to assess the relationships between serum PG and clinicopathologic factors of gastric adenocarcinoma. MATERIALS AND METHODS: Serum PG concentrations were measured in 94 subjects who were classified into (a) a control group (50 subjects) without abnormal endoscopic finding on a health checkup, or (b) a gastric cancer group (44 subjects) who had surgery at Daegu Catholic University Hospital between Nov. 2008 and May 2009. Receiver operator characteristic curves were utilized to select the most suitable test. Using different cutoff points, sensitivity and specificity were calculated. We compared preoperative serum PG levels with several clinicopathologic findings for patients with gastric adenocarcinoma. RESULTS: The Serum PG I:II ratio was the most useful as a screening test. The sensitivity and specificity of PG screening for gastric cancer were, respectively, 81.8% and 82%. The cut off point correlated with the type of intestinal cancer (Lauren classification; P=0.003), tumor stage (P=0.001), and gastric adenocarcinoma with peritumoral chronic atrophic gastritis (P=0.036). CONCLUSION: Serum PG levels were found to be a potentially useful screening test and to correlate with clinicopathologic factors in gastric cancer patients. But, in order to use serum PG found in a health checkup for gastric cancer as a clinical application a large scale study is recommended.
